Mirren Mandalia is Senior Director, Business Development for Ethicon Inc., part of Johnson & Johnson Medtech. In this role he’s responsible to identify technology and capabilities gaps that can be addressed through external business arrangements, including licensing, mergers, acquisitions, partnerships, co-marketing, supply and other structures. He also leads and influences the development of strategies and business cases for new opportunities that are aligned with the goals of the business.

Mirren joined Johnson & Johnson in 2013 and prior to his current role he was part of the London Innovation Center where he was Senior Director, New Ventures and Transactions responsible for leading R&D collaborations and investments in early-stage companies in EMEA for Johnson & Johnson MedTech. Prior to Johnson & Johnson Mirren worked at The Boston Consulting Group in London where he developed strategies to grow and diversify businesses, as well as identify and complete due diligence on prioritized targets for license and acquisition.

Mirren trained as a surgeon at St. George’s Medical School, University of London, and Imperial College in London, and has experience in a many surgical specialties, with specialist training in Plastics & Reconstructive Surgery.  He is a Member of the Royal College of Surgeons and holds an MBA from London Business School.